Exactech News (NASDAQ:EXAC)

DateTimeSource
Headline
07/27/20174:30PMBWExactech Q2 Revenue $67.3 Million On Continuing Strong Extremities Revenue
Q2 Net Income $4.8 Million; Diluted EPS $0.33 Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that revenue for the second quarter of 2017 increased 2% to $67.3 million from $66.1 million in the second quarter... More...>>
07/13/20175:36PMBWExactech Schedules Second Quarter 2017 Earnings Release and Conference Call
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, hip and knee will release its second quarter 2017 financial results on Thursday, July 27, 2017. A copy of the earnings release will be available at http://www.hawkassociates.com. The company... More...>>
06/29/20179:25AMBWExactech Introduces New Computer-Assisted Software Application for Simplified Guidance in Total Knee Replacement
Surgeon Reports Success with First Case Using ExactechGPS TKA PLUS Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced the introduction of ExactechGPS® TKA PLUS, a new software application that provides orthopaedic... More...>>
06/22/20179:15AMBWExactech Expands Presence in Japan with Newly Approved Shoulder, Knee and Hip Replacement Systems
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that the company marked the first clinical use of recently approved shoulder, knee and hip replacement systems in Japan this quarter. These surgeries coincide... More...>>
06/12/201710:37AMBWAlteon® HA Femoral Hip Stem Rounds Out Big Week of First Surgeries for Exactech
Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced that the first surgeries using the new Alteon® HA Femoral Hip Stem took place last week. The total hip replacements were performed by implant design team members Joseph... More...>>
06/06/20178:30AMBWExactech Announces Successful First Surgeries with New Equinoxe® Preserve Stem and ExactechGPS® Shoulder Application
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today a successful first surgery using the new Equinoxe® Preserve stem, a conservative shoulder treatment option designed to preserve humeral bone in shoulder replacement... More...>>
05/31/20179:15AMBWExactech Announces Successful First Surgeries with Truliant® Knee System
Surgeons welcome new design for improved efficiency and reproducibility Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, is pleased to announce that the first surgeries using the new Truliant® Knee System were performed yesterday... More...>>
05/15/201710:52AMBWExactech Receives 510(k) Clearance for Computer-Assisted Shoulder Arthroplasty Technology
ExactechGPS® Shoulder Application showcased in two live surgeries to more than 150 shoulder specialists at recent Masters Course Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today it has received clearance... More...>>
04/25/20174:04PMBWExactech Q1 Revenue Up 6% to $69.5 Million on 21% Extremities Growth
Q1 Net Income $4.6 Million; Diluted EPS $0.32 Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that revenue for the first quarter of 2017 increased 6% to $69.5 million from $65.3 million in the first quarter... More...>>
04/12/201710:15AMBWExactech Schedules First Quarter 2017 Earnings Release and Conference Call
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, hip and knee will release its first quarter 2017 financial results on Tuesday, April 25, 2017. A copy of the earnings release will be available at http://www.hawkassociates.com. The company... More...>>
03/14/20178:55AMBWExactech Announces Full Launch of Three Revision Systems & Expansion of Advanced Surgical Technologies at AAOS 2017 Annual Me...
Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today its lineup of products to be showcased at the company’s educational exhibit, Booth #1433, at the American Academy of Orthopedic Surgeons (AAOS) 2017 Annual Meeting... More...>>
03/13/20178:55AMBWExactech Announces Investor Presentation at 12th Annual CanaccordGenuity Musculoskeletal Conference
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, will update investors at the 12th Annual CanaccordGenuity Musculoskeletal Conference in San Diego on Tuesday, March 14, 2017. The presentation by Exactech CEO and President... More...>>
02/21/20177:29AMBWExactech 2016 Revenue Up 7% to $257.6 Million, Q4’16 Revenue Increased 6% to $66.2 Million
Extremities Revenues Reached $100.3 Million, up 16% vs. Prior Year Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that revenue for 2016 increased 7% to $257.6 million from $241.8 million in 2015. Domestic... More...>>
02/13/201711:03AMBWExactech Schedules Fourth Quarter and Year-End 2016 Earnings Release and Conference Call
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, hip and knee will release its fourth quarter and year-end 2016 financial results before the market opens on Tuesday, February 21, 2017. A copy of the earnings release will be available... More...>>
01/31/20174:01PMBWExactech Announces Divestiture of Spine Assets and Restructuring Charges
With the goals of increasing productivity, enhancing profitability of its worldwide business, and strengthening its focus on core competencies, Exactech, Inc., (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, hip, knee and spine, has announced the restructuring of its Spine... More...>>
10/31/20164:04PMBWExactech Q3 Revenue Up 7% to $59.9 Million. Net Income up 10% to $3.2 Million. Diluted EPS $0.22 vs. $0.20.
Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for hip, knee, extremity, spine and biologic materials, today announced revenue of $59.9 million for the third quarter of 2016, a 7% increase from $56.2 million in the third quarter of 2015. On a constant currency basis, revenue... More...>>
10/24/20169:12AMBWExactech Schedules Third Quarter 2016 Earnings Release and Conference Call
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, hip, knee, and spine, will release its third quarter financial results after the market closes on Monday, October 31, 2016. A copy of the earnings release will be available at http://www.hawkassociates.com. The... More...>>
10/24/20169:05AMBWExactech Schedules Third Quarter 2016 Earnings Release and Conference Call
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, hip, knee, and spine, will release its third quarter financial results after the market closes on Monday, October 31, 2016. A copy of the earnings release will be available at http://www.hawkassociates.com. The... More...>>
10/13/20169:00AMBWExactech Breaks Ground in Foot and Ankle Market with Successful First Surgery
Product Expansion Capitalizes on Successful Extremities Business Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, hip, knee, and spine, announced today a successful first surgery using its new Vantage® Total Ankle System, the newest addition to the Exactech... More...>>
10/12/20161:40PMBWNew Studies Support Exactech’s Knee, Shoulder and Computer-Assisted Surgery Technologies
Exactech Innovations Presented at International Scientific Conference Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, today reported that studies involving its knee and shoulder joint replacement innovations and its ExactechGPS® guided personalized... More...>>
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V:us D:20170821 10:16:03